Morgan Stanley’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $54 | Sell |
|
|||||
|
2024
Q4 | $549 | Buy |
|
|||||
|
2024
Q3 | $1.25K | Hold |
|
|||||
|
2024
Q2 | $1.42K | Sell |
|
|||||
|
2024
Q1 | $99.3K | Sell |
|
|||||
|
2023
Q4 | $41.9K | Buy |
|
|||||
|
2023
Q3 | $25.1K | Buy |
|
|||||
|
2023
Q2 | $31.4K | Hold |
|
|||||
|
2023
Q1 | $25.1K | Buy |
|
|||||
|
2022
Q4 | $23.2K | Sell |
|
|||||
|
2022
Q3 | $51K | Sell |
|
|||||
|
2022
Q2 | $69K | Buy |
|
|||||
|
2022
Q1 | $131K | Buy |
|
|||||
|
2021
Q4 | $314K | Sell |
|
|||||
|
2021
Q3 | $562K | Buy |
|
|||||
|
2021
Q2 | $419K | Buy |
|
|||||
|
2021
Q1 | $224K | Buy |
|
|||||
|
2020
Q4 | $44K | Buy |
|